Ionis Pharmaceuticals | Rentekostnader



Interest Expense On Debt Endring Dato
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Astellas Pharma 4.23B 821M 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Celltrion KRW 18.38B 907.05M 2024-09
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Ecofibre AUD 761K 773K 2024-06
Exelixis 23.4M 3.9M 2023-09
Halozyme Therapeutics USD 4.54M 16K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Moderna USD 6M 0 2024-12
Neuren Pharmaceuticals 0 0 2024-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
OPKO Health USD 17.36M 9.88M 2024-09
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Qiagen NV USD 11.14M 337K 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Ionis Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.